Rugged, Massimo, Matteo Fassan, and David Y. Graham. "Epidemiology of gastric cancer." Gastric Cancer. Springer, Cham, 2015. 23-34.
The cancers is found in nearly all organs in the body, they are named based on the organ that they; affected. Gastric cancer is one of the known death related cancer worldwide. And that are really found in all regions of the world, this also makes it be a huge threat to both diagnostic and clinical because of its challenge in its advanced stage. When a poor prognosis is present with limited treatment options, Helicobacter Pylori the likely common factor for its infection, Epstein-Barr virus infection may be suspected. Some of the coursing issues can be found to the high intake of salt, smoking, and some genetic component that are familiar to the primary prevention such as the H. pylori eradication that are mostly recommended. As the growing knowledge between the phenotype alterations with the molecular mechanisms present in gastric cancer, making it be carcinogenesis, presently there is no available biomarkers are developed for the used for gastric cancer in its secondary prevention stage.
One of the aggressive disorders of gastric cancer; the disease usually continues to have its impact on global health. Despite the total decline on the provenance over many decades now. Gastric cancer is as deadly as it was ranked the fourth most common deadly sympathetic of cancer in the world. And also the second leading cause of all kind of cancer leading deaths worldwide. From the global point of view, the diseases have been the trend to its decreasing incidence of gastric cancer. Knowing the role of H. Pylori pathogen as the tumorigenesis of cancer increases its incidence of the younger generation. It's shows the part played by the biological agents in the treatment of gastric cancer. Lastly, I agreed on the above article that gastric cancer is so deadly and its treatment is hard to get its treatment.
Miller, Kimberly D., et al. "Cancer treatment and survivorship statistics, 2016." CA: a cancer journal for clinicians 66.4 (2016): 271-289
The numbers of cancer fighters are increasing slightly from the advancement in the dictation and this treatment with the increasing aging population. The American Cancer Society with the National Cancer Institution collaboration has removed the figure of currents and approaching survival from the statistics in their surveillance, epidemiology, treatment and its result of cancer type from their evidence in the national cancer database with the treatment effects. From the American cancer history, more than 15.5 million people are living with cancer as at 1st January 2016. As this figure has been projected to rise to more than 20 million by 1st January 2026, The three common cancer are the prostate cancer amounting to (3,306,760), followed by colon and rectum cancer with (724, 690) and the melanoma with (614, 460) in male and (3,560,570) for breast cancer in female, uterine quantity (757,190). From this data further, the (57%) have survived from the diagnoses from the past ten years. While more than (47%) are aged (70 years) and above. It has found that people that have the history of cancer have unique therapeutic as well as psychosocial wants, this needs valuation and running from the main health upkeeps. As their rise in the number of tools that are assisting the patients such as the caregivers, evidence-based capitals are the optimized care.
The increase in the number of the survivors keeps rising due to the aging of the improvement and population within the dictation following by treatment. As the public health community to fight survives of cancer. Its elimination is in collaborations with the American Cancer Society together with the cancer institute. The present pattern for treatment used for the more common cancer types are described to the information surveillance. This work had been done very well, and the date into it had been accepted as acceptable surveillance for the treatment of cancer in America. Due to its facts that fact are found in the figure stated can be true fully due to it's clearly sharing of knowledge. And the understanding of the limited medication the need for cancer fighters and the proactive consider and the mange the issues there increasing the number of funds can help the caregivers, patients, and health care benefactors present in the different stage and treatment.
Schumacher, Ton N., and Robert D. Schreiber. "Neoantigens in cancer immunotherapy." Science 348.6230 (2015): 69-74.
The discovery of the T-Cells help in the control of the different kinds of human cancer is good. The nature of the antigens allows the immune system to differentiate the cancer cells from the noncancerous cells have long become obscure.
In my view, the present of innovation and technology have made it possible to dissect the immune in the response and treatment of cancer by the use of biomarkers in the cancer immunotherapy.
Brabletz, Thomas, et al. "EMT in cancer." Nature Reviews Cancer 18.2 (2018): 128.
The first evidence for this type of cancer was determined by the use of cell cultures, from that time the evidence (in in-vivo) became known and widely reported as well as being actively reported.
The present on the evidence are not the most ranked things, but the cure of the said cancer in the importance.
Cite this page
Technology, Medicine and Cancer Annotated Bibliography. (2022, Nov 20). Retrieved from https://proessays.net/essays/technology-medicine-and-cancer-annotated-bibliography
If you are the original author of this essay and no longer wish to have it published on the ProEssays website, please click below to request its removal:
- Theoretical and Conceptual Frameworks in Understanding Disparities in Health Care
- South East Medical Center Case Study
- Essay Sample on Abortion Legalization
- Portability Principle Violation Under the Canada Health Act Essay
- Research Paper on Western Diet: A Health Risk
- Essay Example on Liquidation Damages: A Remedy for Breach of Contract
- Essay Example on Record Thoughts: Family Morning Routine in Household of Five